Jubilant Pharmova Ltd (BOM:530019)
₹ 1236.95 -19.4 (-1.54%) Market Cap: 195.93 Bil Enterprise Value: 213.85 Bil PE Ratio: 33.14 PB Ratio: 3.30 GF Score: 76/100

Q2 2022 Jubilant Pharmova Ltd Earnings Call Transcript

Oct 22, 2021 / 11:30AM GMT
Release Date Price: ₹604.1 (-1.25%)
Operator

Ladies and gentlemen, good day, and welcome to Jubilant Pharmova Limited Earnings Conference Call for the quarter and half year ended September 30, 2021. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Vineet Mayer, Head of Investor Relations at Jubilant Pharmova Limited. Thank you, and over to you.

Vineet Mayer
Jubilant Pharmova Limited - Manager of IR

Thank you, Stanford. Good evening, everyone. Thank you for being with us on our Q2 FY '22 earnings conference call. I would like to remind you that some of the statements made on the call today could be forward-looking in nature, and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.

On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. Arvind Chokhany, Group CFO; Mr. Pramod Yadav, CEO, Jubilant Pharma; Mr. Giuliano Perfetti, CEO, Jubilant Biosys; Mr. Syed Kazmi, CEO, Jubilant Therapeutics; and Mr. Arun

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot